BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

599 related articles for article (PubMed ID: 16676968)

  • 1. A new family of mono- and dicarboxylic ruthenium complexes [Ru(DIP)2(L2)]2+ (DIP = 4,7-diphenyl-1,10-phenanthroline): synthesis, solution behavior, and X-ray molecular structure of trans-[Ru(DIP)2(MeOH)2][OTf]2.
    Caspar R; Cordier C; Waern JB; Guyard-Duhayon C; Gruselle M; Le Floch P; Amouri H
    Inorg Chem; 2006 May; 45(10):4071-8. PubMed ID: 16676968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Luminescent cyclometalated Rh(III), Ir(III), and (DIP)2Ru(II) complexes with carboxylated bipyridyl ligands: synthesis, X-ray molecular structure, and photophysical properties.
    Waern JB; Desmarets C; Chamoreau LM; Amouri H; Barbieri A; Sabatini C; Ventura B; Barigelletti F
    Inorg Chem; 2008 Apr; 47(8):3340-8. PubMed ID: 18341373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. cis-trans photoisomerization in [Ru(DIP)2(MeOH)2][OTf]2: synthesis, NMR, X-ray structure of the trans-isomer and photophysical properties.
    Amouri H; Waern JB; Caspar R; Barbieri A; Sabatini C; Zanelli A; Barigelletti F
    Dalton Trans; 2007 Jun; (21):2179-86. PubMed ID: 17514339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coordination of 9-ethylguanine to the mixed-ligand compound alpha-[Ru(azpy)(bpy)Cl2] (azpy = 2-phenylazopyridine and bpy = 2,2'-bipyridine). An unprecedented ligand positional shift, correlated to the cytotoxicity of this type of [RuL2Cl2] (with L = azpy or bpy) complex.
    Hotze AC; van der Geer EP; Caspers SE; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    Inorg Chem; 2004 Aug; 43(16):4935-43. PubMed ID: 15285670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactions of potent antitumor complex trans-[Ru(III)Cl4(indazole)2]- with a DNA-relevant nucleobase and thioethers: insight into biological action.
    Egger A; Arion VB; Reisner E; Cebrián-Losantos B; Shova S; Trettenhahn G; Keppler BK
    Inorg Chem; 2005 Jan; 44(1):122-32. PubMed ID: 15627368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
    Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
    Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Replacement of chlorides with dicarboxylate ligands in anticancer active Ru(II)-DMSO compounds: a new strategy that might lead to improved activity.
    Bratsos I; Serli B; Zangrando E; Katsaros N; Alessio E
    Inorg Chem; 2007 Feb; 46(3):975-92. PubMed ID: 17257042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Half-sandwich Ru II[9]aneS3 complexes structurally similar to antitumor-active organometallic piano-stool compounds: preparation, structural characterization and in vitro cytotoxic activity.
    Bratsos I; Jedner S; Bergamo A; Sava G; Gianferrara T; Zangrando E; Alessio E
    J Inorg Biochem; 2008; 102(5-6):1120-33. PubMed ID: 18279961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. meso-[{Ru(phen)2}2(mu-HAT)]4+: a high-affinity DNA hairpin probe {HAT = 1,4,5,8,9,12-hexaazatriphenylene; phen = 1,10-phenanthroline}.
    Smith JA; Morgan JL; Turley AG; Collins JG; Keene FR
    Dalton Trans; 2006 Jul; (26):3179-87. PubMed ID: 16802035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eilatin as a bridging ligand in ruthenium(II) complexes: synthesis, crystal structures, absorption spectra, and electrochemical properties.
    Gut D; Goldberg I; Kol M
    Inorg Chem; 2003 Jun; 42(11):3483-91. PubMed ID: 12767184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and structure of ruthenium(IV) complexes featuring N-heterocyclic ligands with an N-H group as the hydrogen-bond donor: hydrogen interactions in solution and in the solid state.
    Díez J; Gimeno J; Merino I; Rubio E; Suárez FJ
    Inorg Chem; 2011 Jun; 50(11):4868-81. PubMed ID: 21557560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and characterisation of ruthenium complexes containing a pendent catechol ring.
    O'Brien L; Duati M; Rau S; Guckian AL; Keyes TE; O'Boyle NM; Serr A; Görls H; Vos JG
    Dalton Trans; 2004 Feb; (4):514-22. PubMed ID: 15252512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ruthenium(II) mixed-ligand complex containing 2-(4'-benzyloxy-phenyl)imidazo[4,5-f][1,10]phenanthroline: synthesis, DNA-binding and photocleavage studies.
    Tan LF; Wang F; Chao H; Zhou YF; Weng C
    J Inorg Biochem; 2007 Apr; 101(4):700-8. PubMed ID: 17316812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
    Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
    Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diastereoselective synthesis of coordination compounds: a chiral tripodal ligand based on bipyridine units and its ruthenium(II) and iron(II) complexes.
    Hamann C; Von Zelewsky A; Neels A; Stoeckli-Evans H
    Dalton Trans; 2004 Feb; (3):402-6. PubMed ID: 15252546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium complexes of substituted hydrazine: new solution- and solid-state binding modes.
    Dabb SL; Messerle BA; Otting G; Wagler J; Willis A
    Chemistry; 2008; 14(32):10058-65. PubMed ID: 18803189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Half-sandwich RuII-[9]aneS3 complexes with dicarboxylate ligands: synthesis, characterization and chemical behavior.
    Bratsos I; Birarda G; Jedner S; Zangrando E; Alessio E
    Dalton Trans; 2007 Sep; (36):4048-58. PubMed ID: 17828366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ruthenium polypyridine complexes of tris-(2-pyridyl)-1,3,5-triazine-unusual building blocks for the synthesis of photochemical molecular devices.
    Schwalbe M; Karnahl M; Görls H; Chartrand D; Laverdiere F; Hanan GS; Tschierlei S; Dietzek B; Schmitt M; Popp J; Vos JG; Rau S
    Dalton Trans; 2009 May; (20):4012-22. PubMed ID: 19440601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heteroleptic arene ruthenium complexes based on meso-substituted dipyrrins: synthesis, structure, reactivity, and electrochemical studies.
    Yadav M; Singh AK; Maiti B; Pandey DS
    Inorg Chem; 2009 Aug; 48(16):7593-603. PubMed ID: 19610658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Areneruthenium(II) 4-acyl-5-pyrazolonate derivatives: coordination chemistry, redox properties, and reactivity.
    Marchetti F; Pettinari C; Pettinari R; Cerquetella A; Cingolani A; Chan EJ; Kozawa K; Skelton BW; White AH; Wanke R; Kuznetsov ML; Martins LM; Pombeiro AJ
    Inorg Chem; 2007 Oct; 46(20):8245-57. PubMed ID: 17727269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.